Northern Trust Corp Has $2.59 Million Position in Entellus Medical Inc (ENTL)

Northern Trust Corp lifted its stake in shares of Entellus Medical Inc (NASDAQ:ENTL) by 42.8% during the second quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 156,218 shares of the medical technology company’s stock after purchasing an additional 46,857 shares during the quarter. Northern Trust Corp owned 0.71% of Entellus Medical worth $2,587,000 as of its most recent SEC filing.

Other large investors also recently added to or reduced their stakes in the company. Bank of New York Mellon Corp raised its stake in shares of Entellus Medical by 29.4% during the 2nd quarter. Bank of New York Mellon Corp now owns 40,783 shares of the medical technology company’s stock valued at $675,000 after purchasing an additional 9,270 shares during the period. Nicholas Company Inc. raised its stake in shares of Entellus Medical by 1,052.3% during the 2nd quarter. Nicholas Company Inc. now owns 247,685 shares of the medical technology company’s stock valued at $4,101,000 after purchasing an additional 226,190 shares during the period. William Blair Investment Management LLC raised its stake in shares of Entellus Medical by 10.5% during the 2nd quarter. William Blair Investment Management LLC now owns 431,187 shares of the medical technology company’s stock valued at $7,140,000 after purchasing an additional 40,853 shares during the period. Vanguard Group Inc. raised its stake in shares of Entellus Medical by 77.8% during the 1st quarter. Vanguard Group Inc. now owns 424,823 shares of the medical technology company’s stock valued at $5,862,000 after purchasing an additional 185,833 shares during the period. Finally, Goldman Sachs Group Inc. bought a new stake in shares of Entellus Medical during the 1st quarter valued at $423,000. Institutional investors own 70.96% of the company’s stock.

Entellus Medical Inc (NASDAQ:ENTL) opened at $15.98 on Monday. The company has a debt-to-equity ratio of 0.32, a current ratio of 1.92 and a quick ratio of 1.71. Entellus Medical Inc has a one year low of $11.47 and a one year high of $20.34.

A number of equities analysts have weighed in on the company. Zacks Investment Research lowered Entellus Medical from a “buy” rating to a “hold” rating in a research note on Tuesday, October 31st. BidaskClub lowered Entellus Medical from a “buy” rating to a “hold” rating in a research note on Tuesday, August 1st. Piper Jaffray Companies restated a “buy” rating and issued a $21.00 target price on shares of Entellus Medical in a research note on Tuesday, August 22nd. Finally, Canaccord Genuity restated a “hold” rating and issued a $17.00 target price on shares of Entellus Medical in a research note on Tuesday, October 17th. Two equities research analysts have rated the stock with a sell rating, three have issued a hold rating and four have issued a buy rating to the stock. The stock has an average rating of “Hold” and a consensus price target of $21.17.

In other news, VP Timothy B. Petrick sold 2,000 shares of the stock in a transaction dated Friday, September 22nd. The stock was sold at an average price of $18.00, for a total transaction of $36,000.00. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Also, VP Stephen R. Paidosh sold 25,000 shares of the stock in a transaction dated Wednesday, September 13th. The shares were sold at an average price of $17.54, for a total value of $438,500.00. The disclosure for this sale can be found here. Insiders sold a total of 92,150 shares of company stock worth $1,740,652 over the last 90 days. Corporate insiders own 7.70% of the company’s stock.

TRADEMARK VIOLATION NOTICE: “Northern Trust Corp Has $2.59 Million Position in Entellus Medical Inc (ENTL)” was originally posted by Transcript Daily and is the property of of Transcript Daily. If you are reading this report on another website, it was copied illegally and republished in violation of U.S. & international copyright & trademark legislation. The legal version of this report can be read at https://transcriptdaily.com/2017/11/27/northern-trust-corp-has-2-59-million-position-in-entellus-medical-inc-entl.html.

Entellus Medical Company Profile

Entellus Medical, Inc is a medical technology company. The Company is focused on delivering patient and physician experiences through products designed for the minimally invasive treatment of chronic and recurrent sinusitis in both adult and pediatric patients. Its three core product lines, XprESS Multi-Sinus Dilation Systems, MiniFESS Surgical Instruments, and FocESS Imaging & Navigation, are designed to enable ear, nose and throat (ENT), physicians to perform a range of procedures in the ENT physician office and to simplify operating room-based treatment.

Want to see what other hedge funds are holding ENTL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Entellus Medical Inc (NASDAQ:ENTL).

Institutional Ownership by Quarter for Entellus Medical (NASDAQ:ENTL)

Receive News & Ratings for Entellus Medical Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Entellus Medical Inc and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply